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Abstract
The role of socioeconomic status (SES) in explaining racial/ethnic disparities in diabetes remains
unclear. We investigated disparities in self-reported diabetes complications, and the role of macro
(e.g., income, education) and micro (e.g., ‘owning a home’ or ‘having a checking account’) SES
indicators in explaining these differences. The sample included individuals with a diagnosis of
diabetes (N=795) who were on average 55 years old, and 55.6% non-Hispanic White, 25.0%
African American, and 19.4% Hispanic. Approximately 8% reported nephropathy, 35% reported
retinopathy, and 16% reported cardiovascular disease. There were significant disparities in the
rates of complications among non-Hispanic White, African American and Hispanic participants,
with Hispanics having the highest rates of nephropathy, retinopathy, and cardiovascular disease.
Macro SES indicators (e.g., income) mediated racial differences (i.e., non-Hispanic Whites vs.
African Americans) in self-reported retinopathy, a combination of macro and more micro SES
indicators (e.g., education, income, and ‘owning a home’ or ‘having a checking account’)
mediated racial/ethnic differences (i.e., non-Hispanic Whites vs. Hispanics) in self-reported
cardiovascular disease, and only micro SES indicators (e.g., ‘owning a home’ or ‘having a
checking account’) mediated differences between lower income SES racial/ethnic minority groups
(i.e., African Americans vs. Hispanics) in self-reported retinopathy and cardiovascular disease.
Findings underscore that indicators of SES must be sensitive to the outcome of interest and the
racial/ethnic groups being compared.
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Research literature dating back to 1960's consistently reports racial and ethnic disparities in
the prevalence of diabetes,1 performance of diabetes-self-management behaviors,2, 3,access
to diabetes care,4 the quality of diabetes care, 3, 5, 6 risk factors for diabetes-related
complications,7, 8 the presence of diabetes-related complications,9, 10 and rates of diabetes-
specific and all-cause mortality.9-12 Multiple disciplines continue to search for underlying
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biological, psycho-social, and contextual explanations for racial and ethnic disparities for the
purpose of developing interventions to effectively target these mechanisms and, in turn,
reduce disparities in diabetes.13, 14 Recently, it has been suggested that socioeconomic status
(SES) is a stronger determinant of diabetes status and outcomes than race/ethnicity,1, 15-17
and thus may be an underlying mechanism driving racial and ethnic disparities.1, 17 The
extent to which SES explains diabetes disparities is not well understood in part because the
contribution of SES may vary by population and endpoint under investigation, and in part
because of the suboptimal measurement of SES.
In the United States and many other countries, racial and ethnic minority groups are more
likely than majority groups to have low incomes and less education. This poses the
important question of whether widely accepted disparities in diabetes are really attributed to
race/ethnicity (a non-modifiable factor) or SES (a potentially modifiable factor). The
implication being, if SES, a commonly measured factor, were a better marker for other
established risk factors in diabetes (e.g., body mass index [BMI],18 diet,19 physical
activity,20, 21 and hypertension18, 22), it could be easily assessed and used to target
interventions. Further, it suggests that upstream efforts to reduce racial and ethnic
socioeconomic inequalities may help attenuate racial and ethnic disparities in diabetes.
While the literature on racial and ethnic disparities in diabetes incidence is large, well
characterized, and generally consistent, the literature on racial and ethnic disparities in long-
term diabetes complications is not. Fewer studies have been conducted regarding
complications of diabetes, and they generally suggest that the rates of diabetes complications
vary by complication type and by racial and ethnic minority group.23-25 Notwithstanding
this variation, in general, racial and ethnic minorities with diabetes have higher rates of
long-term complications relative to non-Hispanic Whites.26 For example, rates of early and
end-stage kidney disease (proteinuria) are 4 times higher among African Americans and 2.5
times higher among Hispanics compared to non-Hispanic Whites.27, 28 Rates of retinopathy
are 3 times higher among Hispanics and twice as high in African Americans compared to
non-Hispanic Whites.23, 29 Rates of diabetes-related blindness are only half as high for non-
Hispanic Whites as they are for the rest of the population.30, 31 Further, while there is no
clear evidence for disparities in coronary artery disease (CAD) among individuals with
diabetes, there are disparities in the risk factors for CAD, with Hispanics and African-
Americans being more likely than non-Hispanic Whites to have hypertension24 and worse
glycemic control,25, 32 and African Americans being more likely than non-Hispanic Whites
to have deleterious lipid profiles.33 Most data in this regard compare African American or
Hispanic groups to a non-Hispanic White reference group, but very few compare these
groups to each other. As a result, relatively little is known about disparities between African
American and Hispanics with diabetes, which limits our ability to prioritize and target
intervention efforts to those groups at the greatest risk for diabetes-related complications.
A major limitation of studies exploring SES as a mediator of racial and ethnic disparities in
health is the overly simplified operationalization of socioeconomic status.34 SES is often
limited to crude indicators of income and education.34, 35 Yet, studies of other health
conditions suggest that the contribution of SES varies depending on the SES indicator, how
the indicator is specified (i.e., variable levels), and by the type of health outcome under
investigation.36 SES is multidimensional and might best be operationalized with multiple
indicators, combined according to the research question at hand.34, 35 This is particularly
relevant for research questions that go beyond non-Hispanic White-minority differences to
address health disparities among minority populations.
Assessment of education, while seemingly straightforward, may be suboptimal as a single
indicator of SES. Minority populations may be likely to share overall low levels of
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education. Furthermore, equivalent educational attainment between minorities and non-
Hispanic Whites in the US may not confer equivalent health benefits. This effect may be
more pronounced for immigrant populations educated outside the mainland U.S. such as
those of Hispanics heritage.
Assessment of income is also challenging. Minority populations may be more likely to rely
on informal sources of financial support that are less regular and more difficult to quantify
than work-related income. They may support and be supported by family members outside
of the household and therefore have difficulty specifying ‘household’ size and income. They
may also have seasonal patterns of employment that make reporting monthly income
inapplicable. Therefore, examining the impact of SES on racial/ethnic health disparities may
require the use of more sensitive and easily specified indicators of SES (e.g., measures of
assets [e.g., home ownership], engagement with the financial system [e.g., having a
checking account], financial stability [e.g., experiencing a sharp drop in income, worsening
financial situation], and financial strain [e.g., having difficulty making ends meet, having
difficulty paying bills]37).
This study investigated racial and ethnic differences in self-reported diabetes complications,
and the contribution of various indicators of SES in explaining observed differences, after
controlling for demographic and diabetes characteristics. We sought to explore the
usefulness of a range of SES indicators in explaining disparities between racial and ethnic
minorities and non-Hispanic Whites, and between racial and ethnic minorities. We
hypothesized that the crude SES indicators (e.g., income and education) may explain
differences between non-Hispanic Whites and racial and ethnic minorities, but may not
explain differences between minority groups.
Methods
Participants and procedures
Participants included a convenience sample of adults who self-reported a diagnosis of
diabetes and were attending the 2002-2005 American Diabetes Association health fairs in
the northeastern U.S. Investigators hosted a booth with educational material on diabetes and
depression for all fair attendees, and a space for adult passersby with diabetes to participate
in an anonymous on-site questionnaire. Trained research assistants administered the
questionnaire, provided clarification and answered questions as needed, and compensated
participants $5 for their time. A subsample of participants who reported depressive
symptoms signed an informed consent form; other participants were not required to, as the
remainder of the questionnaire was deemed innocuous by the investigators’ institutional
review board.
Measures
Race/ethnicity—Self-identified race/ethnicity was reported by respondents from the
following options: “non-Hispanic White, European American,” “Black, African American,”
“Latino, Hispanic,” “Native American, American Indian,” “Asian, Asian American, Pacific
Islander,” and “Mixed, from more than one group.”
Socioeconomic status (SES) indicators—We selected eight SES indicators to
measure different aspects of SES, including income, education, assets (home ownership),
engagement with the financial system (having a checking account), financial stability
(experiencing a sharp drop in income, worsening financial situation), and financial strain
(having difficulty making ends meet, and having difficulty paying bills).37 To measure
macro SES indicators, participants were asked to estimate annual income before taxes (0 =
Osborn et al. Page 3
J Natl Med Assoc. Author manuscript; available in PMC 2013 December 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
<10K, 1 = 10-20K, 2 = 21-40K, 3 = 41-60K, or 4 = >61K), and to report their highest
educational attainment (1 = less than high school, 2 = high school, 3 = some college or
vocational school, 4 = college degree, or 5 = graduate or professional school). To measure
micro SES indicators, participants were asked: do you own your own dwelling? (0 = no, 1 =
yes), do you have a checking account? (0 = no, 1 = yes), how hard is it to make ends meet?
(1 = hard, 2 = not hard/not easy, or 3 = easy), have you ever experienced a sharp drop in
income? (0 = no, 1 = yes), do you have difficulty paying bills? (0=no, 1 = yes), and how
would you describe your financial situation? (0 = getting worse, 1 = staying the same, or 2 =
getting better).
Diabetes complications—The survey asked in lay language about physician-diagnosed
nephropathy (diabetes-related kidney problems), retinopathy (diabetes-related vision
problems), or cardiovascular disease (heart disease), with 0 = no or 1 = yes as response
options. These questions were based on the U.S. Centers for Disease Control and
Prevention's Behavioral Risk Factor Surveillance System questions for patient report of
physician diagnosis of disorders such as hypercholesterolemia38 and arthritis.39
Covariates—We controlled for demographic characteristics, including age as a continuous
variable, and sex and insurance status as dichotomous variables. While insurance status is
often associated with race/ethnicity,4 health outcomes,40, 41 and SES,42 traditionally defined
by education and income,1, 34, 35, 43 it does not fully explain racial/ethnic disparities in
health.40, 41, 44 Furthermore, our sample showed overall high levels of insurance status
(90.7%). For these reasons, we treated insurance status as a covariate in our analyses.
We also controlled for diabetes characteristics, including years since a diagnosis of diabetes
and BMI kg/m2 as continuous variables, and diabetes type and insulin use as dichotomous
variables. Self-reported height and weight were used to calculate BMI kg/m2. A point-of-
care device assessed glycemic control (HbA1c).
Analyses
The numbers of “Native Americans, American Indians,” “Asians, Asian Americans, Pacific
Islanders,” and “Mixed, from more than one group” in the sample were too few to analyze
as distinct groups, and there is no theoretical justification for combining them into an
“Other” category. We therefore restricted the analyses to “non-Hispanic Whites, European
Americans,” “Blacks, African Americans,” and “Latinos, Hispanics.” Data were analyzed
using means, frequencies, and cross tabulations to calculate descriptive statistics. Chi-square
tests for categorical variables and the the Kruskal-Wallis non-parametric test for continuous
variables tested race/ethnicity differences by demographic characteristics, SES indicators,
and diabetes characteristics. Chi-square tests also tested the bivariate relationship between
each SES indicator and self-reported nephropathy, retinopathy, and cardiovascular disease.
At least a dozen methods for testing hypotheses about mediation have been proposed.45 Of
these approaches, bootstrapping45, 46 is the currently recommended approach 47 because it
does not require a significant effect of the predictor on the outcome for mediation to occur;
it has more power, maintains reasonable control over the Type 1 error rate; and, for multiple
meditator models, it provides the most powerful and reasonable methods of obtaining
confidence limits for specific indirect effects (i.e., mediators) – in particular, bias corrected
(BC) and accelerated (BCa) bootstrapping.48 Thus, we conducted a series of indirect effect
tests with BCa bootstrap (5000 cases) estimation to examine whether race/ethnicity had an
indirect effect on the likelihood of reporting nephropathy, retinopathy, or cardiovascular
disease via each SES indicator adjusted for every other SES indicator and all other
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covariates. All analyses were performed using SPSS version 19.0. A 2-sided P value of less
than .05 was considered statistically significant.
Results
Sample
The sample of 795 adults with diabetes was predominately female (64.7%), middle-aged (M
= 55.2 years SD ± 13.3), diagnosed with type 2 diabetes (80.9%) for an average M = 10.4
years (SD ± 10.5), insured (90.7%), and not taking insulin (63.2%). The sample included
55.6% “ non-Hispanic Whites, European Americans,” 25.0% “Blacks, African Americans,”
and 19.4%“Latinos, Hispanics.” Approximately 28% of the sample reported an annual
income of <20K and 12% reported less than a high school education, but 65% reported at
least some college. The average BMI was M = 31.6 kg/m2 (SD ± 7.2) and the average
HbA1c was M = 7.3 (SD ± 1.7). Approximately 8% of the sample reported physician-
diagnosed nephropathy, 35% reported retinopathy, and 16% reported cardiovascular disease.
Sample characteristics and racial and ethnic differences by demographic characteristics, SES
indicators, and diabetes characteristics can be found in Table 1.
Bivariate relationships
There were significant racial and ethnic differences on six of the eight SES indicators (all
tests, p<.001). Overall, Whites reported higher incomes, more education, and were more
likely to report ‘owning a home’, ‘having a checking account’, and ‘having difficulty
making ends meet’, and were less likely to report ‘difficulty paying bills’ than both African
Americans and Hispanics. African Americans reported higher incomes, more education,
were more likely to report ‘owning a home’ and ‘having a checking account’, and were less
likely to report ‘difficulty paying bills’ compared to Hispanics. However, African
Americans were more likely than Hispanics to report ‘having difficulty making ends meet’
and ‘ever experiencing a sharp drop in income’.
Of the six SES indicators significantly associated with race/ethnicity, four (i.e., education,
income, ‘owning a home’, and ‘having a checking account’) were also associated with at
least one observed diabetes complication. Participants with lower incomes were more likely
than participants with higher incomes to report having nephropathy (p<.01), retinopathy (p<.
001), and cardiovascular disease (p<.001). Participants with less education were more likely
than participants with more education to report having nephropathy (p<.001) and
retinopathy (p<.001). Participants who ‘did not own a home’ were more likely than
participants who ‘owned a home’ to report having nephropathy (p<.01) and retinopathy (p<.
001). Participants who ‘did not have a checking account’ were more likely than participants
who ‘had a checking account’ to report having nephropathy, retinopathy, and cardiovascular
disease (all tests, p<.001). ‘Ever experiencing a sharp drop in income’ or ‘having difficulty
paying bills’ were not associated with any of the observed complications. Only the four SES
indicators that were associated with both race/ethnicity and at least one observed diabetes
complication were included in our bootstrap analyses.
Tests of mediation
Table 2 presents the indirect effects of each race/ethnicity comparison on each complication
via the combined set of four SES indicators (total) and each individual indicator (education,
income, ‘owning a home’, ‘having a checking account’) adjusted for age, sex, insurance
status, BMI, diabetes type, diabetes duration, and insulin use.
Nephropathy—While African Americans were as likely as non-Hispanic Whites to report
having nephropathy (total effect = 0.30, p=.63), Hispanics were more likely than African
Osborn et al. Page 5
J Natl Med Assoc. Author manuscript; available in PMC 2013 December 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Americans and non-Hispanic Whites to report having nephropathy (total effect = 1.42, p=.
03, and total effect = 1.77, p<.001, respectively). These differences became non-significant
when adjusted for the four SES indicators (direct effect of Hispanic vs. African American
race/ethnicity = 0.87, p=.29 and direct effect of Hispanic vs. non-Hispanic White race/
ethnicity = 0.85, p=.24, respectively). However, the degree of difference between Hispanic
and African American participants or Hispanic and non-Hispanic White participants on
reporting nephropathy was neither explained by racial/ethnic differences on the combined
set of SES indicators (total indirect effect = 0.43, 95% BCa bootstrap CI of -0.86 to 2.17 and
total indirect effect = 0.84, 95% BCa bootstrap CI of -0.18 to 2.02) nor by racial/ethnic
differences on any one SES indicator (i.e., education, income, ‘owning a home’ or ‘having a
checking account’).
Retinopathy—Hispanics were significantly more likely than African Americans to report
having retinopathy (total effect = 0.90, p=.02), and this difference became non-significant
when adjusted for the four SES indicators (direct effect = 0.53, p=.25). The degree of
difference between Hispanics and African Americans on having retinopathy was not
explained by Hispanic and African American differences on the combined set of SES
indicators (total indirect effect = 0.51, 95% BCa bootstrap CI of −0.06 to 1.13), but was
explained by Hispanic and African American differences on ‘owning a home’ (indirect
effect = 0.25, 95% BCa bootstrap CI of 0.02 to 0.60) and ‘having a checking account’
(indirect effect = 0.36, 95% BCa bootstrap CI of 0.00 to 0.83).
Hispanics were also significantly more likely than non-Hispanic Whites to report having
retinopathy (total effect =1.52, p<.001), and this difference remained significant when
adjusted for the four SES indicators (direct effect = 1.10, p<.01). Furthermore, the degree of
difference between Hispanic and non-Hispanic White participants on having retinopathy
was neither explained by Hispanic and White differences on the combined set of SES
indicators (total indirect effect = 0.46, 95% BCa bootstrap CI of −0.18 to 1.05) nor by any
one SES indicator.
African Americans were as likely as non-Hispanic Whites to report having retinopathy at the
P <.05 cutoff, but would have been more likely than non-Hispanic Whites to report having
retinopathy at the 0.10 cutoff (total effect = 0.59, p=.06), becoming non-significant at the
that level when adjusted for the four SES indicators (direct effect = 0.45, p=.18). While the
degree of difference between African Americans and non-Hispanic Whites on having
retinopathy was not explained by African American and non-Hispanic White differences on
the combined set of SES indicators (total indirect effect = 0.14, 95% BCa bootstrap CI of
-0.10 to 0.44), it was explained by African American and non-Hispanic White differences on
income (indirect effect = 0.16, 95% BCa bootstrap CI of 0.02 to 0.39).
Cardiovascular disease—Hispanics and African Americans did not differ on reporting
cardiovascular disease (total effect = −0.37, p=.37). The degree of difference between
Hispanics and African Americans on having cardiovascular disease, even if not significant,
was not explained by Hispanic and African American differences on the combined set of
SES indicators (total indirect effect = 0.30, 95% BCa bootstrap CI of −0.38 to1.13), but was
explained by Hispanic and African American differences on ‘having a checking account’
(indirect effect = 0.69, 95% BCa bootstrap CI of 0.13 to 1.34).
Hispanics were significantly more likely than non-Hispanic Whites to report having
cardiovascular disease (total effect = 0.93, p=.02), and this effect became non-significant
when adjusted for the four SES indicators (direct effect = −0.34, p=0.58). The degree of
difference between Hispanics and non-Hispanic Whites on having cardiovascular disease
was explained by Hispanic and non-Hispanic White differences on the combined set of SES
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indicators (total indirect effect = 1.08 and a 95% BCa bootstrap CI of 0.12 – 1.88), but not
by Hispanic and non-Hispanic White differences on any 1 SES indicator.
African Americans were significantly more likely than non-Hispanic Whites to report
having cardiovascular disease (total effect = 1.31, p<.001), and this difference remained
significant when adjusted for the four 4 SES indicators (direct effect = 1.10, p<.01). The
degree of difference between African Americans and non-Hispanic Whites on having
cardiovascular disease was neither explained by African American and non-Hispanic White
differences on the combined set of SES indicators (total indirect effect = 0.17 and a 95%
BCa bootstrap CI of -0.04 to 0.46) nor by African American and non-Hispanic White
differences on any 1 SES indicator.
Discussion
The main findings of this study are that: (1) disparities in self-reported diabetes
complications exist among Hispanics, African Americans and non-Hispanic Whites even
after controlling for numerous demographic and diabetes characteristics; (2) SES indicators
help to explain, and in some cases account for, some disparities in diabetes complications;
(3) various indicators of SES differentially mediate the relationships between race/ethnicity
and diabetes complications. Specifically, where SES did mediate, macro SES indicators
(e.g., income) mediated racial differences (i.e., non-Hispanic Whites vs. African Americans)
in self-reported retinopathy, a combination of macro and more micro SES indicators (e.g.,
education, income, and ‘owning a home’ or ‘having a checking account’) mediated racial/
ethnic differences (i.e., non-Hispanic Whites vs. Hispanics) in self-reported cardiovascular
disease, and only micro SES indicators (e.g., ‘owning a home’ or ‘having a checking
account’) mediated differences between lower SES racial/ethnic minority groups (i.e.,
African Americans vs. Hispanics) in self-reported retinopathy and cardiovascular disease.
Hispanics were more likely to report having nephropathy and retinopathy than African
Americans or non-Hispanic Whites, and were more likely to report having cardiovascular
disease than non-Hispanic Whites. The overall worse profile for Hispanics is consistent with
recent evidence49, 50 that challenges the ‘Hispanic paradox’, which a decade or so ago
posited that Hispanics in the U.S. had comparable or better health outcomes than non-
Hispanic Whites, despite what their socioeconomic situations would predict. Contributing to
that literature is our finding that Hispanics had higher rates of self-reported complications as
well as the lowest incomes, least amount of education, were least likely to own a home or
have a checking account, and had the most difficulty paying bills compared to non-Hispanic
Whites and African Americans. Interestingly, Hispanics were the least likely to report
having a hard time ‘making ends meet’. Other work has shown that Hispanics may have
social networks that can provide resources to buffer the deleterious effects of financial
deprivation.51
In this study, the Hispanic-non-Hispanic White difference in having cardiovascular disease
was mediated by the combined set of SES factors including education, income, ‘owning a
home’ and ‘having a checking account’. As predicted, macro SES indicators (i.e., income
and education) were useful in explaining Hispanic- non-Hispanic White differences in
health. On the other hand, Hispanic-African American differences in having retinopathy
were mediated only by ‘owning a home’ or ‘having a checking account, and Hispanic-
African American differences in having cardiovascular disease were solely mediated by
‘having a checking account’. Education may not be sensitive among lower-SES minority
groups, given that attendance at schools in poor neighborhoods may not confer the same
educational experiences and benefits as educational attainment at schools in higher SES
environments. Similarly, income may not be sensitive among populations with overall low
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levels of financial resources. SES indicators that are more sensitive, discrete and easily
specified such as ‘owning a home’ or ‘having a checking account’, may be required to detect
socioeconomic influences in such populations. In addition, ‘owning a home’ or ‘having a
checking account’ may be particularly useful when assessing the SES of Hispanic groups
because these factors may be affected by immigration status and acculturation.
‘Having difficulty making ends meet’, ‘having difficulty paying bills’, ‘ever experiencing a
sharp drop in income, or ‘perceiving one's financial situation as getting worse, staying the
same, or getting better’ were not related to the observed diabetes complications. Temporally
distal indicators of SES that do not capture recency and duration of one's SES, and/or
indicators of SES that reflect one's attitude toward finances rather than finances per se, may
not be the most sensitive measures of SES, particularly when assessing differences between
lower-SES, racial/ethnic minority groups.
Taken together, these findings underscore that indicators of SES must be sensitive to the
SES milieu of particular respondents. That is, measures must be specific to the outcome of
interest, the racial and ethnic groups being compared, and the analytic approach used to
untangle observed differences. Until it can be clearly established which indicators of SES
are important for specific populations or health outcomes, we recommend a comprehensive
approach to SES assessment that goes beyond the standard use of income and education. We
also suggest that ‘owning a home’ or ‘having a checking account’ are promising indicators
that should be validated in future studies.
Limitations of this study include a relatively smaller number of “Hispanic” participants; the
inability to differentiate between Hispanic subgroups or represent other ethnic-minority
groups; a recruitment strategy that may have yielded a non-representative sample of adults
who attend health fairs, limiting generalizability to the general population; and self-reported
measures of SES, diabetes characteristics (e.g., diabetes type, duration, insulin use), and
diabetes-related complications. Also, we found similar rates of nephropathy for African
Americans and non-Hispanic Whites, a finding that is inconsistent with published data and
likely reflects the limits of self-reported medical diagnoses. Finally, we did not account for
the variety of system-level, provider-level, and patient-level factors (e.g., access to care,
therapeutic inertia, patient education, and medication adherence) that may impact the
association between race/ethnicity and diabetes-related complications. The major strengths
of this study include a diverse sample of non-Hispanic White, African American, and
Hispanic participants who were recruited from the community rather than a clinical setting,
the use of multiple measures of SES, and careful control of demographic and diabetes
characteristics.
Conclusions
Consistent with recent literature,1 continuing to focus on racial and ethnic status as the
primary determinant of disparities in diabetes-related outcomes diverts effort from socio-
medical interventions such as improving social circumstances, access to effective care, and
upstream social policies that increase equity. Research to further this agenda must
adequately measure socio-economic determinants of health.
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